𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Antiplatelet therapy and development of hypertension induced by recombinant human erythropoietin in uremic patients

✍ Scribed by Caravaca, Francisco; Pizarro, José L; Arrobas, Manuel; Cubero, Juan J; García, María C; Perez-Miranda, Manuel


Book ID
109882640
Publisher
Nature Publishing Group
Year
1994
Tongue
English
Weight
711 KB
Volume
45
Category
Article
ISSN
0085-2538

No coin nor oath required. For personal study only.


📜 SIMILAR VOLUMES


Effect of recombinant human erythropoiet
✍ Tàssies, Dolors; Reverter, Joan Carles; Cases, Aleix; Calls, Jordi; Escolar, Gin 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 67 KB 👁 2 views

Recombinant human erythropoietin improves platelet function in uremia through the correction of anemia, but this effect can be seen also before the hematocrit rise. We studied 12 hemodialyzed patients (seven men, five women) who received recombinant human erythropoietin (40 IU kg -1 i.v., three time

Kinetics of reticulocyte maturity fracti
✍ Sowade, Olaf; Sowade, Birgit; Brilla, Kay; Franke, Werner; Stephan, Peter; Gross 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 186 KB

We evaluated the changes in reticulocyte maturity fractions and indices, as measured by flow cytometry, during preoperative treatment with recombinant human erythropoietin (epoetin beta) in cardiac surgery patients. A total of 72 patients was enrolled in this double-blind, randomized, placebo-contro

Ratio of baseline erythropoietin (EPO) l
✍ Navapun Charuruks; Narin Voravud; Wacharee Limpanasithikul 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 107 KB

## Abstract Purpose: Recently, recombinant human erythropoietin (rhEPO) was introduced for the management of anemia in malignancy. To identify an indicator for a favourable response to rhEPO, 28 anaemic cancer patients undergoing chemotherapy and treated with rhEPO were evaluated. Methods: Patients